Kindly give this answer for dnb exam taking reference from Williams Obs and recent updates
"WHO labour care guide" partogram intrapartum
"labour care guide" WHO intrapartum
WHO Labour Care Guide 2020 components advantages disadvantages vs partograph
WHO Labour Care Guide components sections advantages disadvantages over partograph
WHO Labour Care Guide components sections admission labor progress fetal maternal monitoring shared decision making
"labour care guide" implementation outcomes caesarean
| Domain | Advantage |
|---|---|
| Active phase threshold | Uses 5 cm (not 3-4 cm) to define active labor onset - based on updated Friedman/Zhang labor curve evidence; reduces unnecessary early intervention |
| No rigid action line | Replaces the arbitrary 4-hour action line with individualized alert-based decision-making, reducing unnecessary cesarean sections and oxytocin augmentation |
| Second stage coverage | Monitors the second stage of labor - the conventional partograph largely ignores this phase |
| Fetal monitoring | More structured documentation of FHR, moulding, caput, and amniotic fluid - supports better fetal surveillance |
| Supportive care integration | Companionship, hydration, mobility, and analgesia are formally documented - promoting evidence-based respectful maternity care |
| Shared decision-making | Structured patient communication documentation reduces unnecessary interventions and supports informed consent |
| Numeric format | Uses numbers instead of graphs, making it easier and faster to complete - particularly useful in settings with varying literacy levels among staff |
| Shift handover | All patient information on a single sheet improves communication during duty handovers |
| Audit and quality improvement | Designed as a quality improvement tool; supports facility-level audit of intrapartum care |
| LMIC applicability | Feasibility and acceptability demonstrated across low- and middle-income settings (Vogel et al., 2021) |
| Reduced cesarean rates | RCT evidence (Vogel et al., 2024, Nature Medicine [PMID: 38291297]): 5.5% absolute reduction in cesarean rate in nulliparas; 18% lower oxytocin augmentation |
| Improved labor outcomes | Comparative study (Vishnu Priya et al., 2026, Cureus [PMID: 41728452]): significantly shorter active phase duration, higher vaginal delivery rates, shorter hospital stay with LCG vs. Modified Partograph |
| Domain | Limitation |
|---|---|
| No pictorial overview | Abandonment of the graphical partogram means no visual trend-at-a-glance; clinicians must mentally compute progress from numbers - increases cognitive load |
| Latent phase gap | The LCG covers active labor (≥5 cm) only; there is no standardized protocol for monitoring women in latent phase (3-4 cm), leaving a clinical gap |
| More complex and time-consuming | More sections to complete increases documentation time - a significant challenge in busy, understaffed units |
| Training requirement | Effective use requires intensive training and behavioral change; staff accustomed to the partograph need reorientation |
| No alert/action line | While this is an advantage conceptually, the absence of a clear threshold may lead to delayed decision-making in low-resource settings where guidelines are strictly protocol-based |
| Labor companion logistics | Recommendation for a companion of choice may be difficult to implement structurally in overcrowded labor wards |
| Resource constraints | Supportive care components (analgesia, hydration, mobility) require resources and infrastructure not always available in LMICs |
| Limited high-quality RCT data | The 2024 Nature Medicine trial was a pilot (n=26,331) - confidence intervals were wide (RR 0.85, 95% CI 0.54-1.33); definitive trials are still awaited |
| Feasibility in single-midwife settings | Individual 1:1 monitoring implied by the LCG is not feasible where one midwife manages multiple laboring women simultaneously |
| Not yet universally endorsed | Despite FIGO endorsement (2025), uptake remains variable; WHO itself recommends phased implementation rather than abrupt replacement |
| Feature | Conventional WHO Partograph | WHO Labour Care Guide (2020) |
|---|---|---|
| Active phase threshold | ≥3-4 cm | ≥5 cm (Zhang curve) |
| Alert/Action lines | Yes (4-hour action line) | Alert column only; no action line |
| Second stage monitoring | No | Yes |
| Supportive care | No | Yes (companionship, hydration, analgesia, mobility) |
| Shared decision-making | No | Yes (dedicated section) |
| Format | Graphical curve | Numerical tabular |
| Pain documentation | No | Yes (numeric pain score) |
| Quality audit tool | No | Yes |
| Fetal monitoring detail | Basic | Comprehensive |
Williams Obstetrics reference point: Williams (25th ed., Ch. 22) describes the evolution from Friedman's curve to the Zhang/MFMU curves showing that labor at 5 cm is the reliable onset of active phase, that second-stage duration thresholds should be individualized, and that continuous support in labor reduces cesarean rates - all of which are foundational principles operationalized in the LCG.
Kindly explain with simple flow charts and diagrams
┌─────────────────────────────────────────────────────────────────┐
│ WHO LABOUR CARE GUIDE (LCG) 2020 │
│ Single A3 Sheet | 7 Major Sections │
└──────────────────────────┬──────────────────────────────────────┘
│
┌────────────────┼────────────────┐
▼ ▼ ▼
┌──────────────────┐ ┌──────────────┐ ┌───────────────────┐
│ SECTION 1 │ │ SECTION 2 │ │ SECTION 3 │
│ ADMISSION & │ │ LABOUR │ │ FETAL │
│ LABOUR INFO │ │ PROGRESS │ │ CONDITION │
│ │ │ │ │ │
│ • Patient ID │ │ • Cx dilation│ │ • FHR (30 min) │
│ • Gestational age│ │ (numeric) │ │ • Amniotic fluid │
│ • Parity │ │ • Head descent│ │ • Moulding/Caput │
│ • Cervical dil. │ │ • Contractions│ │ • Fetal position │
│ • Membranes │ │ • ALERT │ │ │
│ • Liquor colour │ │ COLUMN │ │ │
└──────────────────┘ └──────────────┘ └───────────────────┘
┌────────────────┼────────────────┐
▼ ▼ ▼
┌──────────────────┐ ┌──────────────┐ ┌───────────────────┐
│ SECTION 4 │ │ SECTION 5 │ │ SECTION 6 │
│ MATERNAL │ │ SUPPORTIVE │ │ MEDICATIONS & │
│ CONDITION │ │ CARE ★NEW★ │ │ INTERVENTIONS │
│ │ │ │ │ │
│ • BP, Pulse, Temp│ │ • Companion │ │ • Oxytocin dose │
│ • Urine output │ │ present? │ │ • IV fluids │
│ • O2 saturation │ │ • Hydration │ │ • Drugs given │
│ • Pain score★NEW │ │ • Mobility │ │ • Time-stamped │
│ │ │ • Analgesia │ │ │
└──────────────────┘ └──────────────┘ └───────────────────┘
│
▼
┌─────────────────────────┐
│ SECTION 7 │
│ SHARED DECISION- │
│ MAKING ★NEW★ │
│ │
│ • Clinical discussions │
│ • Informed consent │
│ • Patient autonomy │
│ • Communication log │
└─────────────────────────┘
★NEW★ = Sections absent in conventional partograph
CONVENTIONAL PARTOGRAPH WHO LABOUR CARE GUIDE
───────────────────────── ─────────────────────────
Woman arrives in labour Woman arrives in labour
│ │
▼ ▼
Cervical dilation Cervical dilation
assessed (VE) assessed (VE)
│ │
▼ ▼
┌─────────────────┐ ┌─────────────────────┐
│ Active phase at │ │ Active phase at │
│ 3 - 4 cm │ │ ≥ 5 cm │
│ (Friedman) │ │ (Zhang/MFMU curve) │
└────────┬────────┘ └──────────┬──────────┘
│ │
▼ ▼
Plot on GRAPH Record NUMERICALLY
(graphical curve) (tabular format)
│ │
▼ ▼
┌────────────────────────────┐ ┌────────────────────┐
│ ALERT LINE drawn │ │ ALERT COLUMN │
│ (1 cm/hr expected rate) │ │ < 1 cm/hr over │
│ │ │ 4 hours = REVIEW │
└────────────┬───────────────┘ └─────────┬──────────┘
│ │
▼ ▼
┌────────────────────────────┐ ┌──────────────────────┐
│ ACTION LINE at 4 hours │ │ NO ACTION LINE │
│ to the right of alert │ │ Individualised │
│ = MANDATORY INTERVENTION │ │ clinical judgement │
└────────────┬───────────────┘ └─────────┬────────────┘
│ │
▼ ▼
Cesarean / Oxytocin ┌────────────────────────┐
augmentation mandated │ SHARED DECISION with │
by the line │ woman + provider + │
│ companion │
└────────────────────────┘
Woman in Active Labour (Cx ≥ 5 cm)
│
▼
┌─────────────────────────┐
│ Monitor every 30 min: │
│ • FHR │
│ • Contractions │
│ • Maternal vitals │
│ • Cx dilation (4 hrly) │
└────────────┬────────────┘
│
┌────────────▼─────────────┐
│ Any ALERT TRIGGERED? │
│ • Cx dilation < 1cm/4hr │
│ • Abnormal FHR │
│ • Meconium-stained fluid│
│ • Maternal deterioration│
│ • Pain score high │
└──────┬──────────┬────────┘
│ │
NO YES
│ │
▼ ▼
Continue ┌────────────────────────────┐
monitoring │ CLINICAL REVIEW │
│ (NOT automatic Cx/oxytocin│
│ - unlike old partograph) │
└─────────────┬──────────────┘
│
┌────────────▼───────────────┐
│ SHARED DECISION-MAKING │
│ Provider + Woman + Companion│
└────────────┬────────────────┘
│
┌─────────────────┼──────────────────┐
▼ ▼ ▼
Watchful Augment labour Expedite
waiting (oxytocin) delivery
+ support if indicated (Cx section)
STAGES OF LABOUR
─────────────────────────────────────────────────────────────
LATENT PHASE │ ACTIVE PHASE (1st Stage) │ 2nd STAGE
(0 - 4 cm) │ (5 cm - 10 cm, full dil.) │ (pushing)
│ │
──────────────────┼───────────────────────────────┼───────────────
Conventional │ ██████████████████████████████│ ✗ NOT
Partograph │ Covered (3cm onwards) │ COVERED
│ │
──────────────────┼───────────────────────────────┼───────────────
WHO LCG 2020 │ ████████████████████████ │ ██████████████
(no latent │ Covered from 5 cm │ COVERED
protocol) │ │ ★ NEW ★
│ │
──────────────────┴───────────────────────────────┴───────────────
LEGEND:
██ = Covered ✗ = Not covered ★ = Newly added in LCG
WHO LABOUR CARE GUIDE
│
┌───────────────┴───────────────┐
▼ ▼
✅ ADVANTAGES ❌ DISADVANTAGES
───────────────── ────────────────────
✅ Active phase at 5 cm ❌ No graphical overview
(less over-diagnosis) (harder to spot trends)
✅ No rigid action line ❌ Latent phase (<5cm)
(fewer unnecessary Cx) has NO protocol
✅ Covers 2nd stage ❌ More time-consuming
of labour to fill in
✅ Supportive care ❌ Requires intensive
documented staff training
✅ Pain score included ❌ Labor companion
logistics difficult
✅ Shared decision-making in overcrowded wards
documented
❌ No alert/action line
✅ Numeric format - may delay decisions
easier to complete in protocol-driven
settings
✅ Improves handover
between shifts ❌ Limited RCT evidence
(pilot data only so far)
✅ Promotes respectful
maternity care ❌ Resource-intensive
(companionship, analgesia,
✅ RCT: 5.5% ↓ in mobility all need
cesarean rate infrastructure)
(Vogel 2024)
╔═══════════════════════════════════════════════════════════════╗
║ WHAT'S NEW IN LCG vs CONVENTIONAL PARTOGRAPH ║
╠═══════════════════════════╦═══════════════════════════════════╣
║ FEATURE ║ PARTOGRAPH │ LCG ║
╠═══════════════════════════╬════════════════╪═══════════════════╣
║ Active phase threshold ║ 3-4 cm │ 5 cm ║
║ Format ║ Graph │ Numeric table ║
║ Alert system ║ Alert + Action│ Alert only ║
║ 2nd stage monitoring ║ ✗ No │ ✅ Yes ║
║ Supportive care ║ ✗ No │ ✅ Yes ║
║ Pain documentation ║ ✗ No │ ✅ Yes ║
║ Labor companion ║ ✗ No │ ✅ Yes ║
║ Shared decision-making ║ ✗ No │ ✅ Yes ║
║ Quality audit tool ║ ✗ No │ ✅ Yes ║
║ Informed consent log ║ ✗ No │ ✅ Yes ║
╚═══════════════════════════╩════════════════╧═══════════════════╝
KEY PHILOSOPHY SHIFT:
Partograph → "Does the curve cross the line?"
LCG → "How is this woman doing overall?"
A L F M S M S
│ │ │ │ │ │ │
│ │ │ │ │ │ └── Shared Decision-Making
│ │ │ │ │ └───── Medications & Interventions
│ │ │ │ └──────── Supportive Care
│ │ │ └─────────── Maternal Condition
│ │ └────────────── Fetal Condition
│ └───────────────── Labour Progress
└──────────────────── Admission Information
Mnemonic: "A Lady Feels Most Safe, Monitored Sincerely"